{{Rsnum
|rsid=308393
|Gene=FGF2
|Chromosome=4
|position=122825464
|Orientation=plus
|GMAF=0.2713
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=FGF2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 76.9 | 18.5 | 4.6
| HCB | 90.7 | 9.3 | 0.0
| JPT | 72.5 | 27.5 | 0.0
| YRI | 11.7 | 41.7 | 46.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 90.7 | 9.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19586755
|Title=Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
}}

{{on chip | 23andMe v3}}